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Chromatin remodelingThe conserved SWI/SNF chromatin remodeling complex uses the energy from ATP hydrolysis to alter local
chromatin environments through disrupting DNA-histone contacts. These alterations inﬂuence transcription
activation, as well as repression. The Drosophila SWI/SNF counterpart, known as the Brahma or Brm complex,
has been shown to have an essential role in regulating the proper expression of many developmentally
important genes, including those required for eye and wing tissue morphogenesis. A temperature sensitive
mutation in one of the core complex subunits, SNR1 (SNF5/INI1/SMARCB1), results in reproducible wing
patterning phenotypes that can be dominantly enhanced and suppressed by extragenic mutations. SNR1
functions as a regulatory subunit to modulate chromatin remodeling activities of the Brahma complex on
target genes, including both activation and repression. To help identify gene targets and cofactors of the
Brahma complex, we took advantage of the weak dominant nature of the snr1E1 mutation to carry out an
unbiased genetic modiﬁer screen. Using a set of overlapping chromosomal deﬁciencies that removed the
majority of the Drosophila genome, we looked for genes that when heterozygous would function to either
enhance or suppress the snr1E1 wing pattern phenotype. Among potential targets of the Brahma complex, we
identiﬁed components of the Notch, EGFR and DPP signaling pathways important for wing development.
Mutations in genes encoding histone demethylase enzymes were identiﬁed as cofactors of Brahma complex
function. In addition, we found that the Lysine Speciﬁc Demethylase 1 gene (lsd1) was important for the proper
cell type-speciﬁc development of wing patterning.r Center, Room 334, Loyola
S. First Avenue, Maywood, IL
).
l rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Within the eukaryotic cell nucleus, chromosomal DNA is ﬁrst
packaged into nucleosomes that are further assembled into a highly
structured nucleoprotein complex called chromatin. Chromatin
organization is a fundamental constraint involved in regulating the
expression of eukaryotic genes, since the presence of a nucleosome
around a binding site blocks the accessibility of most transcription
factors to their cognate binding sequences. The highly conserved SWI/
SNF ATP-dependent chromatin remodeling complex regulates the
expression of many genes by remodeling chromatin in response to
regulatory signals, thus enabling the binding of transcription factors
and activator complexes to regulatory sequences within target genes.
SWI/SNF complexes play critical roles in DNA replication and
repair, RNA Polymerase II transcription, as well as metazoan
embryonic development and postnatal tissue regeneration byregulating cell proliferation, differentiation and survival (Mohrmann
and Verrijzer, 2005; Wu et al., 2009). Components of the complex
were ﬁrst identiﬁed in yeast during two independent genetic screens
as mutants that either lost the ability to switch mating type (SWI for
Switching Deﬁcient) or displayed an inability to grow in sucrose
containing medium (SNF for Sucrose non-fermenting) (Winston and
Carlson, 1992). The yeast and metazoan SWI/SNF complexes are
composed of 8–11 unique subunits with an approximate molecular
mass of 1.2 MDa (Peterson et al., 1994; Smith et al., 2003). The
complex has a single ATPase subunit that is required both in vitro and
in vivo for ATP-dependent chromatin remodeling activity. However,
full in vitro chromatin remodeling activity on mono-nucleosomes and
nucleosomal arrays can be achieved with reconstitution of 4
mammalian “core” subunits, BRG1, INI1/BAF47, BAF170, and BAF155
(Phelan et al., 1999), making it likely that the remaining subunits are
important for complex stability, regulation, and/or targeting.
The Drosophila SWI/SNF counterpart is known as the Brahma
(Brm) complex. The chromatin remodeling activities of the Brm
complex are important for both the activation and repression of gene
transcription during development (Simon and Tamkun, 2002). The
BRM protein co-localizes with RNA Polymerase II on salivary gland
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transcription (Armstrong et al., 2002; Zraly et al., 2003). Microarray
analyses of Brm complex mutants demonstrated that the complex
was likely involved in both transcription activation and repression
(Zraly et al., 2006). The role of Brm complex regulation during gene
activation has been extensively characterized and often involves
recruitment of histone modifying enzymes, such as histone acetyl-
transferases (HATs), and gene speciﬁc transcription factors (Simon
and Tamkun, 2002). The role of the Brm complex in gene repression is
less well understood, and is generally thought to result from the
formation of repressive chromatin within gene promoters or through
associations with co-repressor complexes including histone deacety-
lases and demethylases.
SNF5 is a core component of all puriﬁed SWI/SNF complexes and
serves an essential function in regulating chromatin remodeling
activities. Previous work demonstrated that a dominant negative
mutation in the Drosophila snr1 gene (snr1E1) that encodes a core Brm
subunit, SNF5-Related-1 (SNR1), leads to differential misregulation of
genes required for wing vein and inter-vein cell development
(Marenda et al., 2004), suggesting possible regulatory targets for the
Brm complex in vivo that include components of the EGFR (Epidermal
Growth Factor Receptor), DPP/BMP (Decapapentaplegic/Bone Mor-
phogenetic Protein) and Notch–Delta signaling pathways. These
studies revealed tissue-speciﬁc differential requirements for Brm
complex functions in patterning and allowed us to conclude the
following: (i) The ectopic veins associated with snr1E1 are dependent
on BRM ATPase chromatin remodeling activity; (ii) SNR1 functions to
regulate BRM ATPase activity on speciﬁc gene targets (e.g., rhomboid)
in intervein cells of the wing through collaborations with transcrip-
tional repressors (e.g., NET) and histone deacetylase (HDAC) activity.
These studies revealed that transcription repression by the Brm
complex is due in part to restraint of chromatin remodeling activities
and that the SNR1 subunit has regulatory role to restrict remodeling
activities in a cell-type, tissue-speciﬁc manner (Marenda et al., 2004).
We sought to further address how target genes are selectively
regulated by the Brm complex through studies of SNR1 function, as
this subunit plays a pivotal role in complex dependent gene-speciﬁc
repression. There are two possible mechanisms of SNR1 mediated
complex regulation: (i) physical associations between individual
subunits within the complex and (ii) physical association between the
Brm complex and other coregulatory proteins. We addressed both of
these possibilities and observed an important genetic and physical
interaction between two Brm complex core subunits, SNR1 and MOR.
Speciﬁcally, we found that the highly conserved SNR1 Repeat 2 (R2)
and Coiled-coil regions physically associate with the SWIRM domain
of MOR. Employing a dominant enhancer–suppressor genetic screen
we also identiﬁed histone lysine demethylase enzymes as potential
coregulators of Brm complex remodeling activities. We found that
Lysine Speciﬁc Demethylase-1 (LSD1) genetically and physically
associates with the Brm complex. Further, lsd1 appears to genetically
interact with a subtype of the Brm complex (Polybromo or PBAP) in
the context of wing development. Lastly, we show that LSD1 is
expressed throughout the pupal wing, in both vein and intervein cells,
and that it likely functions in a cell-type speciﬁc fashion to repress
highly conserved EGFR and/or DPP signaling in intervein cells.
Materials and methods
Fly stocks and genetic analyses
All Drosophila stocks were maintained on standard yeast/corn-
meal/dextrose medium at 25 °C, except for snr1E1,e/TM6B,Hu,e which
was maintained at 29 °C. Mutant strains were obtained from private
stocks and the Indiana University-Bloomington Drosophila Stock
Center (BDSC, Bloomington, Indiana). Transgenic RNAi lines were
obtained from the Vienna Drosophila Resource Center (Vienna,Austria). All strains and gene mutants are described in detail in
Flybase (http://ﬂybase.bio.indiana.edu).
Drosophila chromosomal deﬁciency stocks were obtained from the
BDSC. Information on the deﬁciency stocks tested and predicted/
known breakpoints are available upon request. Females of the
genotype snr1E1,e/TM6B,Hu,e were crossed to males harboring the
mutation of interest, unless otherwise indicated. Crosses were carried
out at 29 °C and progeny scored for enhancement or suppression of
the snr1E1 posterior cross vein and/or L2 and L5 veinwing phenotypes,
as described in the text (Marenda et al., 2004, 2003). At least 50 wings
were scored for each interaction cross. Genetic analyses involving
other Brahma complex components were carried out at 25 °C.
P-element mobilizations were carried out using standard genetic
crosses, brieﬂy described as follows. Virgin female y1w67c23; P(w+,
lacW)lid2/CyO ﬂies were crossed to male w−; wgsp1/CyO; Δ2,3 Sb/
TM6B. Virgin w−; lid2/CyO; Δ2,3 Sb/+ were crossed to male w−; Sco/
CyO. Virgins carrying potential excisions (w−; lid2REV/CyO;+/+)were
selected based on the loss ofmini-white gene and individually crossed
to male w−; Sco/CyO ﬂies. w−; lid2REV/CyO siblings were crossed to
build stocks. w−; lid2REV/CyO ﬂies were crossed to Df(2L)ED354/SM6a,
a deﬁciency covering lid. The lid2 insertion is lethal, so the presence of
lid2REV/Df(2L)ED354 progeny indicated that the P-element had been
precisely excised. In order to excise the P-element affecting the Jarid2/
CG3654 gene, virgin females of the genotype y1w67c23; P{w[+mC]y
[+mDint2]=EPgy2} Jarid2EY02717 ﬂies were crossed tow−; wgsp1/CyO;
Δ2,3 Sb/TM6B. Male y1w67c23/Y; CyO/+; P{w[+mC]y[+mDint2]
=EPgy2}Jarid2EY02717/Δ2,3 Sb were crossed to virgin w;TM3/TM6B
ﬂies. Virgin female potential excision recombinants were collected
based on loss of red eye color, w−[+mC]y[+mDint2]=EPgy2}
Jarid2EY02717REV/TM6B, and were individually crossed to male w−;
TM3/TM6B ﬂies. w−;[+mC]y[+mDint2]= EPgy2} Jarid2EY02717REV/
TM6B siblings were crossed to generate stocks.
Yeast two-hybrid protein interaction studies
Yeast two-hybrid interaction analyses were performed to detect
protein–protein interactions using the pRF4-5o and pEG202 vectors
(Finley and Brent, 1994). Four SNR1-B42AD fusions, SNR115–370,
SNR115–240, SNR1240–370, and SNR115–370 G256D have been
previously described (Zraly et al., 2004). The MOR, LSD1, and ADA2
fusions were constructed in the pEG202 vector and tested for protein–
protein interaction with the SNR1 fusions. Full-length mor and lsd1
cDNAs were obtained from the DGRC (http://dgrc.cgb.indiana.edu/)
and regions of interest were ampliﬁed using standard PCR procedures
(ExTaq; Takara, Inc.). Xho1/BamH1 mor fragments and EcoR1/Xho1
lsd1 and ada2a PCR fragments were independently cloned into pSK+,
screened, and subcloned into the bait LexA pEG202 yeast vector. All
constructs were transformed into yeast strains of opposite mating
type (RFY231 and Y309), mated to produce diploids, and assayed for
protein–protein interaction. A positive protein–protein interaction
resulted in binding of the protein complex to an upstream activator
sequence (UAS), resulting in expression of either β-galactosidase
(lacZ), which results in blue colony formation on plates containing
X-gal, or leu2 expression, which allows for growth on plates lacking
leucine, as described previously (Marenda et al., 2004). Each pair
mating was tested in triplicate. The QuikChangeII Site-Directed
Mutagenesis Kit (Stratagene) was utilized to create the speciﬁc
(I350P) point mutations in snr1 sequences according to the
manufacturer's protocols. Mutations were conﬁrmed by sequencing.
Primer sequences are available upon request.
RNAi in cultured S2 cells
Cultured Drosophila S2 cells were incubated with dsRNA to knock-
down the endogenous snr1, mor and brm transcripts, as well as an
unrelated gene CG10465, as described previously (Zraly et al., 2006).
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prepared and protein levels assessed byWestern blot using antibodies
to SNR1, BRM (Zraly et al., 2003), MOR (Mohrmann et al., 2004) and a
control protein, CDK9. Untreated S2 cell extracts were used as a
control to determine endogenous protein levels.
Co-immunoprecipitation and GST-pull down assays
Co-immunoprecipitation (Co-IP) experiments were carried out as
previously described (Zraly et al., 2002) using extracts prepared from
0 to 24 h Oregon-R (wild type) embryos. Extracts (500 μg) were pre-
cleared with protein G-Sepharose then incubated with primary
afﬁnity puriﬁed rabbit polyclonal α-SNR1 (Zraly et al., 2002). Protein
complexes were precipitated using protein G-Sepharose beads. Bound
and unbound proteins were fractionated by SDS-PAGE and analyzed
by western blotting using rabbit α-LSD1 (Di Stefano et al., 2007). The
extract input (E) lane represents 20% (100 μg) of the cleared lysate
used in the IP.
A full-length lsd1 cDNAwas obtained from the Drosophila Genome
Resource Center, (DGRC, University of Indiana, Bloomington) and
regions of interest were ampliﬁed using standard PCR procedures
(ExTaq; Takara, Inc.). EcoR1/Xho1 lsd1 PCR fragments were indepen-
dently cloned into pSK+, screened, and subcloned into pGEX-5X1
(Stratagene). Constructs were generated that fused GST to the LSD1
N-terminal portion (SWIRM) and to the C-terminal portion (Amine
Oxidase). These fusion constructs were transformed into E. coli BL21
cells, incubated at 37 °C for 2 h, induced with 1 mM IPTG, and
harvested 2–3 h later. The N-terminal fusion was grown at 30 °C
following induction, the C-terminal fusion and empty vector controls
were grown at 37 °C. Fusion proteins were solubilized using standard
protocols and equivalent amounts of the fusion proteins as assessed
by Coomassie stained gel analyses were bound to glutathione agarose
beads. GST-pulldown assays were performed as described previously
(Zraly et al., 2004) by incubating wild type Drosophila Oregon R
embryo extracts (500 μg) with the immobilized fusion proteins or GST
alone (Dingwall et al., 1995). Bound proteins were separated by SDS-
PAGE and interactions with the Brm complex were assessed by
Western immunoblot using antibodies to SNR1. The extract lane
contains 20% (100 μg) of the starting material.
Immunohistochemistry
Appropriately staged [stage P7, 34–42 h after pupariation (Bain-
bridge and Bownes, 1981)] pupal wings were dissected, ﬁxed, and
immunostained with α-LSD1 (1:1000) antibody (a kind gift from
Nicolas Dyson). Pupae were removed from pupal cases in phosphate
buffered saline (PBS, pH 7.4) and ﬁxed in 4% formaldehyde for 30 min.
Pupal wings were then dissected in PBST (PBS, 0.1% Triton-X100) and
removed from their cuticular envelopes. Pupal wings were washed 3×
in PBST and then incubated in 10% normal goat serum (blocking) for 1
h at 4 °C. Blocking solution was removed and wings were incubated
with either rabbit α-LSD1 (1:1000) or PBS (negative control) at 4 °CFig. 1. SNR1 interacts directly with the MOR subunit. (A–D) Animals transheterozygous for sn
(wild type) wing has ﬁve longitudinal veins (L1–L5) and two crossveins, Anterior Crossvein
material distal to the PCV (arrow). (C) snr1E1/Df(3R)Exel7327 transheterozygous ﬂies have an
as anterior and posterior to L2 (arrows). (D) mor3/+ enhances the snr1E1/+ ectopic vein ph
PCV and anterior to L2. (arrows). All pictures were taken at the same magniﬁcation (63×) a
REGION 2 (R2) and COILED-COIL, physically interacts with the MOR-SWIRM. SNR1-B42 Ac
SWIRM (442–552)-LexA DNA Binding Domain (DBD) fusions in yeast 2-hybrid analyses. The
REPEAT REGION 2 (R2), and COILED-COIL (CC) domains of SNR1 are indicated. Protein–
galactosidase (blue colony formation) and growth on media lacking leucine. Robust interact
SNR1240–370, both of which contained the C-terminal region, including R2 and the CC. The
SNR1I350P physically associated with the MOR SWIRM. The G256D mutation (as carried in
served as a negative control and exhibited no interaction with SNR1(15–370). (F) Western im
dsRNAs directed against snr1, mor, brm or an unrelated gene control (C) as indicated. Blot
Untreated S2 cell extracts (−) were used as a control for endogenous gene expression leveovernight. Samples were washed 4× in PBST and then incubated with
goat α-rabbit-HRP (1:500) (Sigma) for 1–2 h at room temperature.
Samples were again washed 3× in PBST and then developed as
described previously (Marenda et al., 2004).
Results
The Brm complex subunits SNR1 andMOR directly collaborate to regulate
target genes
Several lines of evidence suggest an important functional
relationship between two highly conserved BRM complex compo-
nents, SNR1 and MOIRA (MOR). First, the mammalian SNR1 (SNF5/
INI1/BAF47/SMARCB1) and MOR orthologs (BAF155/SRG3/SMARCC1
and BAF170/SMARCC2) are required for full BRG1 remodeling activity
in vitro (Phelan et al., 1999). Second, a physical interaction has been
observed betweenmurine SNR1 and MOR orthologs (SNF5 and SRG3)
via the SRG3 SWIRM domain that is important for protein–protein
interactions (Sohn et al., 2007). Third, RNAi-mediated knockdown of
snr1 and mor in cultured Drosophila S2 cells revealed nearly identical
expression proﬁles (Sohn et al., 2007). Finally, genetic epistasis tests
in Drosophila using mutant alleles of snr1 andmor conﬁrmed a strong
in vivo interaction (Marenda et al., 2003). This evidence suggests that
SNR1 and MOR were capable of direct collaboration within the Brm
complex.
The snr1E1 mutant used in these genetic tests is a temperature-
sensitive allele that behaves genetically as both a loss-of-function
hypomorph and a weak dominant-negative (Marenda et al., 2003).
The mutation affects a nearly invariant glycine (G256) residue within
the second repeat region, a highly conserved irregular repeat region
known to be involved in multiple protein–protein interactions.
Heterozygous snr1E1 ﬂies exhibit ectopic wing vein material perpen-
dicular to the posterior cross vein (PCV) and anterior to longitudinal
vein L2 (Fig. 1A). The defects are apparent at the permissive (18 °C)
temperature, with increased penetrance at the restrictive (29 °C)
temperature. The phenotypes are sensitive to snr1 gene dosage and
are enhanced or suppressed by mutations in other Brm complex
genes, revealing that SNR1 directly regulates aspects of Brm complex
activity (Marenda et al., 2003). The mutant phenotypes result from
reduced or compromised SNR1 function, rather than complete
disruption of Brm complex activities (Marenda et al., 2004, 2003) as
snr1E1 produces a stable protein that is assembled into Brm complexes
at both temperatures (Marenda et al., 2003).
We previously observed that a large chromosomal deletion that
completely removes mor (Df(3R)sbd105, pp, Ubxbx-1, sr1, es) acted as a
very mild enhancer of the dominant negative snr1E1 wing phenotype,
while the hypomorphic mor1 allele acted as a strong enhancer
(Marenda et al., 2004). To examine the SNR1–MOR functional
relationship in more detail, we performed genetic interaction tests
between snr1E1 and several unique mor alleles (Brizuela and
Kennison, 1997; Kennison and Tamkun, 1988), as well as a small
deﬁciency (Df(3R)Exel7327). While the original deﬁciency tested, Dfr1E1 and loss of functionmor alleles display a strong genetic interaction. (A) An OregonR
(ACV) and Posterior Crossvein (PCV). (B) snr1E1/+ heterozygous ﬂies have ectopic vein
enhanced ectopic wing vein phenotype, with ectopic material distal to the PCV, as well
enotype. snr1E1/mor3 transheterozygous ﬂies display ectopic vein material distal to the
nd crosses were set at 29 °C. (E) The C-terminal region of SNR1, containing the REPEAT
tivation Domain (AD) fusion proteins were tested for physical interaction with MOR-
SWIRM, SANT, and LEUCINE-ZIPPER (ZIP) domains of MOR, and REPEAT REGION 1 (R1),
protein interactions were assessed by two independent assays, the production of β-
ions were observed between the MOR SWIRM and two SNR1 fusions, SNR115–370 and
structure of the CC is likely not essential for the protein–protein interaction, since the
snr1E1 mutants) strongly interacted with the MOR SWIRM. The LexA-MOR SANT fusion
munoblot using extracts prepared from cultured embryonic S2 cells were treated with
s were probed with antibodies against MOR, BRM, SNR1 and a control protein, CDK9.
ls.
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Table 1
Allele speciﬁc genetic interaction between snr1E1 and mor.
Allele Predicted allele
class
Genotype Total
wings
Severity of
phenotypea
(−) (+) (++)
snr1E1 Weak dominant
negative
snr1E1/+ 207 67 30 3
mor1 Hypomorph mor1/+ 152 94 5 0
snr1E1/mor1 116 31 39 30
mor2 Null mor2/+ 267 100 0 0
snr1E1/mor2 168 97 3 0
mor3 Hypomorph mor3/+ 319 48 38 14
snr1E1/mor3 100 23 15 62
mor4 Hypomorph mor4/+ 106 100 0 0
snr1E1/mor4 230 76 23 1
mor5 Hypomorph mor5/+ 130 66 22 12
snr1E1/mor5 102 46 34 20
mor6 C-terminal
truncation
mor6/+ 241 56 40 4
snr1E1/mor6 148 41 23 36
Df(3R)
Exel7327
Deﬁciency Df(3R)Exel7327/+ 59 92 8 0
snr1E1/Df(3R)Exel7327 118 12 8 80
a Severity of phenotype was scored as follows: (−) normal vein pattern, (+) single
extra vein near posterior cross vein, and (++) two or more wing veins near PCV,
anterior to longitudinal vein L2 or posterior to longitudinal L5. Numbers are expressed
as percentages of the total wings examined for each genotype.
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chromosomal deletion are not well deﬁned, and the genes predicted
to be deleted in the deﬁciency were based on complementation
analyses. Therefore, we chose to test a more accurately described
deﬁciency (Df(3R)Exel7327) with deﬁned endpoints that deletes mor
as well as 18 other surrounding genes.
Strong allele-speciﬁc enhancement of the snr1E1 wing phenotype
was observed with the deﬁciency (Df(3R)Exel7327) and several
hypomorphicmor alleles (mor1,mor3,mor5) and a C-terminal deletion
(mor6) that removes the predicted leucine zipper, a motif important
for homo-oligomerization (Table 1). Flies doubly heterozygous for
snr1E1 and the predicted hypomorph, mor3, or the deﬁciency, Df(3R)
Exel7327, displayed strong enhancement of the snr1E1 wing pheno-
type (Fig. 1A). Other mor mutant alleles, including a predicted null
(mor2), and the predicted hypomorph (mor4) exhibited suppression
of the wing phenotype (Table 1). The most likely explanation for the
opposite genetic interactions observed between snr1E1, the null allele
mor2, and the larger deﬁciency is that the deﬁciency deletes additional
gene(s) that may cooperate with the Brm complex to regulate target
genes, directly or indirectly, or may have an independent role in tissue
patterning.While the exact nature of themor alleles are unknown, our
genetic interaction data suggests that mor4 may affect protein
expression, similar to the decreased protein expression expected
with the mor2 null allele, leading to an overall decrease in total Brm
complex formation. However, mor1, mor3, mor5, and mor6 hetero-
zygotes all display ectopic vein phenotypes, suggesting that these
mutations may alter protein folding, altering the ability of MOR to
regulate Brm complex activities, perhaps by changing the physical
interactions it makes with the other two core complex components,
SNR1 and BRM. These data conﬁrm an important functional
relationship between SNR1 and MOR in regulating Brm complex
target genes.
The BRM, MOR and SNR1 subunits have been proposed to function
as the core components of all Brm and metazoan SWI/SNF complexes.
MOR (BAF155, BAF170) has been postulated to serve as the bridge
between the core subunits (Crosby et al., 1999; Moshkin et al., 2007;
Phelan et al., 1999)making it likely that SNR1 regulatory functions are
mediated through direct contacts with MOR. We ﬁrst sought to
identify a region of SNR1 essential for interacting with MOR by
performing a series of yeast interaction trap analyses (Fig. 1B). The
SNR1 protein is composed of three distinct regions, two irregularrepeat regions (Repeat 1 (R1) and Repeat 2 (R2)) both of which are
essential for heterotypic protein–protein interactions, and a predicted
Coiled-coil (CC) region also possibly involved in protein interactions
(Dingwall et al., 1995; Morozov et al., 1998). The MOR protein
contains several predicted protein interaction motifs, including a
leucine zipper region, SWIRM and SANT domains (Crosby et al., 1999).
We constructed several SNR1 deletion derivatives fused to the B42
activation domain and tested them for interaction with portions of
MOR fused to the LexA DNA binding domain, including the SWIRM
region implicated in mediating interactions between the murine
homologs (Sohn et al., 2007). A robust interaction was observed
between the C-terminal portion of SNR1 (consisting of R2 and CC
regions) and the MOR SWIRM region; however, we did not detect
interactions between SNR1 and the SANT domain.
The COILS program (Lupas et al., 1991) predicts that amino acids
338–364 of SNR1 have approximately 50% probability of forming a
Coiled-coil structure. Within this region M346, I350, M360, and A364
are likely to be involved in the formation and stability of the Coiled-
coil structure, as they are located in the seam joining the two helices.
We used the COILS program to predict the effects of substituting a
proline for each of these residues as this change could considerably
alter the alpha helical structure by forming a kink in the helices. An
I350P conversion would theoretically have the most profound effect
by decreasing the probability of forming a Coiled-coil to less than 1%
(Supplemental Fig. 1). We therefore changed the I350 residue to a
proline and tested the interaction with theMOR SWIRM domain using
yeast two-hybrid analyses. The I350P conversion in the full-length
SNR1 did not disrupt the physical association with the MOR SWIRM
domain, suggesting that the formation of a Coiled-coil structure was
not necessary for the observed protein interaction (Fig. 1B).
To further ascertain whether physical associations between SNR1
and MOR were important for complex assembly or stability, we
depleted SNR1, MOR and BRM in cultured Drosophila S2 cells using
RNAi and tested for subunit stabilities by Western blot (Fig. 1C). We
observed reducedMOR accumulation in cells depleted for either SNR1
or BRM alone, with greater reductions of MOR in cells depleted for
both SNR1 and BRM. Similarly, SNR1 levels were reduced following
RNAi depletion of MOR. Thus, consistent with the widely held view
that protein complex components show decreased stability when
partner proteins are deleted or missing and with previous ﬁndings
(Moshkin et al., 2007; Peterson and Herskowitz, 1992), the stability of
the SNR1 andMOR subunits appears to be at least partly dependent on
assembly of the remodeling complex core components.
Dominant genetic modiﬁer screens to identify SNR1-interacting
coregulators
It is likely that the regulation of BRM complex activities is
dependent not only upon physical associations between complex
subunits, but also association of the complex with coregulatory
proteins. We previously performed candidate genetic screens looking
for dominant enhancement or suppression of the snr1E1-dependent
wing phenotypes (Marenda et al., 2004). In general, we found that
loss of function mutations in vein forming genes dominantly
suppressed the snr1E1 phenotypes, while loss of function mutations
in vein repressing genes showed enhancement. In order to identify
factors that modify SNR1 repression functions in vivo and to identify
possible coregulators of Brm complex activity, we carried out an
unbiased dominant modiﬁer genetic screen using an ordered set of
chromosomal deﬁciencies from the Bloomington Drosophila Stock
Center that removed ~85% of the euchromatic genome (both X and
autosomes). We looked for deﬁciencies that enhanced or suppressed
the wing patterning phenotype associated with the temperature-
sensitive snr1E1mutation in doubly heterozygous ﬂies reared at 29 °C.
Heterozygous snr1E1/+ ﬂies display ectopic wing vein material distal
to the posterior crossvein in this assay (Fig. 1A) (Marenda et al., 2003).
Fig. 2. Dominant modiﬁer screen for enhancers and suppressors of the snr1E1 wing phenotype. Shown is a cytological map of Drosophila melanogaster chromosomes I, II and III and
the locations of deﬁciencies that enhanced and suppressed the snr1E1 ectopic wing vein phenotype. Each chromosome is subdivided into two arms (L and R), and each arm is further
subdivided into 20 cytological markers. Indicated below the cytological map are regions on each chromosome where interacting deﬁciencies have deleted genomic DNA. Black bars
indicate enhancement by the deﬁciency, and gray bars indicate suppression. Arrows show genes within each deﬁciency previously identiﬁed to interact with snr1E1. Open bars
represent deﬁciencies that were synthetically lethal in combination with snr1E1.
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the ectopic wing vein phenotype (N20% reduction); whereas,
enhancement was scored as increased penetrance (N20% increase)
and/or the appearance of additional ectopic vein material. While the
effects of enhancers of the snr1E1 vein phenotype could be observed
throughout the wing, the effects of suppressors were restricted to the
area of the wing being examined (i.e., posterior crossvein and L5
region). In total, 88 of the ~250 deﬁciency lines tested exhibited
strong enhancement (55/88) or suppression (33/88) (Fig. 2; Supple-
mentary Tables 1–3). In addition, two deﬁciencies removing different
portions of the X-chromosome exhibited heterozygous lethality in
combination with snr1E1 (Supplementary Table 1).
As a ﬁrst step towards determining whether our unbiased
approach was sufﬁciently sensitive to identify novel Brm complex-
interacting genes, we correlated the results of the deﬁciency screen
with our earlier candidate genetic screen performed using speciﬁc
mutant alleles (Marenda et al., 2004). In general, deﬁciencies that
removed genes previously identiﬁed as dominant enhancers of the
snr1E1 wing phenotype exhibited similar enhancement (corto, kis, Dl,
bs, sbb, RpII215). There was also a correspondence between the
deﬁciency screen results and several genes previously identiﬁed as
suppressors (S, N, cycE). However, many of the enhancer and
suppressor deﬁciencies removed loci not previously identiﬁed as
interacting with the Brm complex, representing a rich resource for
identifying novel coregulators of Brm complex functions.
A second approach used to validate the deﬁciency screen results
was to identify novel interacting genes (Fig. 3). We ﬁrst narrowed the
interacting region(s) using either a partially overlapping deﬁciency or
mutations in candidate genes removed by the deﬁciency. The
heterozygous Df(3L)81k19 alone does not exhibit a wing patterning
defect (Fig. 3D); however, the deﬁciency was found to dominantly
enhance the snr1E1 phenotype (Fig. 3E). Among the genes predicted to
be removed by that deﬁciency (http://ﬂybase.org), the argos gene was
a likely candidate, as it is a negative regulator of the EGFR pathway
(Schweitzer et al., 1995) involved in wing vein speciﬁcation (Marendaet al., 2006). Heterozygotes containing a mutant argosΔ7 allele with
the snr1E1 mutation exhibited ectopic wing veins (Fig. 3F). Similar
results were obtained using a second argos mutant allele (argos05845;
data not shown). The Df(2R)CX1 deﬁciency has no dominant
heterozygous wing phenotype (Fig. 3G); however, in combination
with snr1E1, we observed strong suppression of ectopic wing veins
(Fig. 3H). The E(Egfr) gene was the most likely candidate among the
deduced genes removed by the deﬁciency. We found that a mutation
in the E(Egfr)B56 gene could dominantly suppress the snr1E1 wing
patterning defect (Fig. 3I). We can conclude that the deﬁciency screen
approach is sufﬁciently sensitive to use as a ﬁrst step for identifying
candidate genes that may interact with the Brm complex to regulate
wing patterning. Moreover, our results have indicated that the EGFR
pathway may depend in part on Brm complex chromatin remodeling
functions to correctly pattern the wing epithelium.
Candidate screen identiﬁes histone demethylase enzymes as potential
Brm complex coregulators
The goal of our dominant enhancer/suppressor screen was to
identify novel coregulators of the Brm complex in controlling gene
expression. Therefore, we looked to see if there was any functional
similarity among candidate transcriptional regulators which geneti-
cally interacted with snr1E1. Several histone lysine demethylase
enzymes (KDMs) were identiﬁed in our screen as potential mediators
of Brm chromatin remodeling activities. There are two ‘families’ of
KDMs (Klose et al., 2006; Klose and Zhang, 2007; Shi and Whetstine,
2007; Swigut and Wysocka, 2007). The Jumonji family has 12
members and is capable of demethylating tri-, di-, and monomethy-
lated lysine residues. A much smaller family of demethylases contains
1 member, LSD1/KDM1, which is only capable of demethylating di-,
and monomethylated (H3K4) lysine residues and in mammalian cell
culture analysis, di-, and monomethylated (H3K9) lysine residues
when in complexes with the Androgen Receptor (AR) (Metzger et al.,
2005). We found that 7 deﬁciencies covering individual histone
Fig. 4. snr1 genetically interacts with histone lysine demethylase enzymes. (A) snr1E1/+ wings display ectopic vein material distal to the PCV (arrow). (B) Wings from Df(3L)AC1/
snr1E1 transheterozygous ﬂies have increased penetrance and expressivity of the ectopic vein phenotype. Note ectopic vein material posterior to L5 and distal to the PCV (arrows).
(C) snr1E1/P(CG3654)EY02717 transheterozygous wings have an enhanced ectopic vein phenotype, with wings displaying ectopic vein material distal to the PCV and anterior to L2
(arrows). (D) The candidate histone demethylase gene covered by the Df(3L)AC1 deﬁciency, P(CG3654)EY02717, has no heterozygous wing phenotype. (E) P-element excision from P
(CG3654)EY02717 reverts the genetic interaction phenotype observed with snr1E1. snr1E1/P(CG3654)EY02717REV transheterozygotes have an ectopic vein phenotype similar to snr1E1/+
siblings [compare (A) to (E)]. (F) The snr1E1 transheterozygous phenotype is dominantly suppressed by Df(2L)Ed354. Note Df(2L)ED354/+; snr1E1/+ wings have no ectopic vein
material near the PCV. (G) The candidate histone demethylase gene covered by the Df(2L)ED354 deﬁciency, lid2, has no heterozygous wing phenotype. (H) Heterozygous lid2
dominantly suppresses the snr1E1 ectopic vein phenotype. lid2/+; snr1E1/+ transheterozygotes have no ectopic veins. (I) Reversion of the lid2 mutation by P-element excision
abolishes the suppression of the snr1E1 phenotype, such that lid2REV/+; snr1E1/+ transheterozygotes have an ectopic vein phenotype similar to snr1E1/+ siblings [compare (A) to (I)].
Fig. 3. Validation of the enhancer/suppressor screen. Shown are examples of deﬁciencies that enhance and suppress the snr1E1 phenotype. Wings displayed are from adult ﬂies
crossed at 29 °C unless otherwise indicated. (A) wild type OregonR wing with longitudinal veins L2, L3, L4, L5, and posterior cross vein (PCV) and anterior cross vein (ACV) labeled.
(B) snr1E1/+, note the weak extra vein present near the PCV. (C) snr1E1/snr1E1 at 18 °C. (D) Df(3L)81k19/+. (E) Df(3L)81k19/snr1E1, note the enhancement of the snr1E1 extra vein
phenotype as manifested by additional vein material posterior to L5. (F) argosDelta7/snr1E1, the argos gene is deleted in Df(3L)81k19 and shows similar enhancement as the deﬁciency
alone. (G) Df(2R)CX1/+. (H) Df(2R)CX1/snr1E1, note the minor notching of the posterior and distal portions of the wing blade that is not present in deﬁciency wings alone as well as
the suppression of the weak snr1E1 vein phenotype. (I) E(Egfr)B56B56/snr1E1, the E(Egfr)B56 gene is deleted in Df(2R)CX1 and shows similar suppression as the deﬁciency alone;
however, the wing notching present in (H) is likely due to an unidentiﬁed interacting locus removed in the deﬁciency.
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wing patterning phenotype (Supplemental Tables 1–3). To better
determine if loss of the particular demethylase gene, and not some
other gene covered by the deﬁciency, was responsible for the
observed genetic interaction, we obtained smaller representative
deﬁciencies for each of the 13 predicted histone demethylase genes
(Klose et al., 2006; Klose and Zhang, 2007) and carried out a candidate
screen by independently testing these deﬁciencies for a geneticTable 2
snr1E1 genetically interacts with histone lysine demethylase enzymes.
Demethylase Genotype Wings Genetic interactiona
snr1E1,e/+ 267
LSD1 (CG17149) snr1E1,e/Df(3L)ED4858 106 Enhancementb
snr1E1,e/P(lsd1)ΔN 206 No effect
snr1E1,brm2,e/P(lsd1)ΔN 62 Enhancementc
JARID (LID) Df(2L)ED354/+;snr1E1,e/+ 128 Suppression
lid1/+; snr1E1,e/+ 144 Suppression
lid2/+; snr1E1/+ 168 Suppression
lid2(REV)/+; snr1E1/+ 60 No effectd
JARID2 (CG3654) Df(3L)AC1/snr1E1,e 120 Enhancemente
snr1E1,e/CG3654EY02717 152 Enhancementf
CG3654EY02717-REV/+ 30 Uniqueg
snr1E1,e/CG3654EY02717-REV 114 No effecth
JHDM2 (CG8165) Df(3R)by10/snr1E1,e 66 Enhancementi
snr1E1,e/P(CG8165)EY01319 116 Enhancement
JHDM3/JMJD2
(CG15835)
Df(2R)Exel6055/+; snr1E1,e/+ 50 Suppressionj
P(2R)(CG15835)KG04636/+;
snr1E1,e/+
136 No effect
JHDM3/JMJD2
(CG33182)
Df(2R)Exel8057/+; snr1E1,e/+ 94 Suppressionh
P(CG33182)aats-val/+;
snr1E1,e/+
136 No effect
JMJD4 (CG7200) Df(2L)Bsc149/+; snr1E1,e/+ 118 Suppression
JMJD5 (CG13902) Df(3L)ED4177/snr1E1,e 40 Suppression
snr1E1,e/P(CG13902)e01240 138 Suppression
JMJD5 (CG10133) snr1E1,e/Df(3L)Exel6119 105 Suppressionh
snr1E1,e/P(CG10133)KG04150 78 No effect
JmjC domain only
(CG5383/PSR)
snr1E1,e/Df(3R)Exel6190 162 Suppression
snr1E1,e/P(EPgy2)EY07193 86 Enhancementk
JmjC domain only
(CG2982)
Df(1)ED6720/X; snr1E1,e/+ 48 Suppression
Df(1)ED6720/Y; snr1E1,e/+ 48 Suppression
P(CG2982)EP1316/+; snr1E1,e/+ 64 Suppression
UTX/UTY
(CG5640)
Df(2L)Bsc206/+, snr1E1,e/+ 142 Suppression
JHDM1
(CG11033)
snr1E1,e/Df(3R)Exel6151 94 Suppression
snr1E1,e/P(CG11033)DG12810 180 Suppression
a Genetic interaction was scored as Enhancement, Suppression, No Effect, or Unique.
A 20% or greater increase in the number of wings displaying the snr1E1 ectopic vein
phenotype or the presence of ectopic vein material distal to the PCV as well as anterior
of L2 or posterior of L5 was classiﬁed as enhancement. A 20% or more decrease in the
number of wings displaying the snr1E1 ectopic vein phenotype was considered
suppression. A unique phenotype is associated with the demethylase mutant alone.
b 90% of Df(3L)ED4858/+ sibling wings displayed an ectopic vein phenotype similar
to that of snr1E1,e/+.
c 33% ofwings display ectopic veinmaterial distal to the PCV aswell as posterior to L5.
d lid2-REV is a P-element excision that completely rescues the lid2 phenotype as well as
the genetic interaction phenotype.
e 24% of wings have ectopic vein material distal to the PCV as well as posterior to L5.
f 12% of wings show ectopic vein material anterior to L2 or posterior to L5, and
ectopic vein material distal to the PCV.
g CG3654EY02717-REV is a P-element excision that rescues the mutant phenotype.
However, 33% of heterozygotes have ectopic vein material distal to the PCV, a
phenotype similar to snr1E1, complicating the analyses.
h Approximately 70% of wings display an ectopic vein distal to the PCV. However,
multiple ectopic veins were not observed, animals, demonstrating that the genetic
interaction observed between snr1E1,e and CG3654EY02717 was due to the presence of a
P-element insertion within the CG3654 gene.
i 23% of wings have ectopic vein material in wingmargins, between L3/L4, or anterior
to L2, as well as distal to the PCV.
j Although the deﬁciency genetically interacted with snr1E1, the candidate gene did
not, suggesting that the interaction with the deﬁciency was either due to loss of an
unknown gene and not from loss of the histone demethylase, or that the particular
demethylase allele tested was weak.
k Opposite genetic interactions were observed with the deﬁciency and the candidate
gene.interaction with snr1E1 (Fig. 4). We found that all 13 deﬁciencies
tested genetically interacted; 3 deﬁciencies enhanced, while 10
deﬁciencies suppressed the snr1E1 ectopic wing vein phenotype
(Table 2). To determine if the observed genetic interactions
were due to loss of the KDM gene, epistasis tests were performed
using P-element insertion lines disrupting several predicted demethy-
lase genes obtained from the Exelixis and Berkeley Drosophila
Genome Project (BDGP) collections, as well as a null allele of lsd1
(lsd1ΔN) (Di Stefano et al., 2007). We tested each of these lines for a
genetic interaction with snr1E1 and found that 4 Jumonji family
histone demethylase mutants, little imaginal discs (lid), CG13902,
CG2982, and CG11033 suppressed the snr1E1 ectopic vein phenotype
and 2 Jumonji members, CG3654 and CG8165, enhanced the
phenotype (Table 2; Fig. 4). Transposase mobilized excision of the
P-element in two of these lines, one that enhanced (CG3654EY02717)
and one that suppressed (lid2) the snr1E1 phenotype, abolished the
genetic interaction phenotype (Table 2; Fig. 4), conﬁrming that the
interactions were not due simply to background effects. Our screen
results provide a novel ﬁnding that in vivo Brm complex chromatin
remodeling functions may be highly dependent on the activity of
histone lysine demethylase enzymes.
LSD1 genetically interacts with Brm complex components
The Brm complex has important roles in regulating gene
transcription, in part by physically associating with transcription
activator proteins (Gutierrez et al., 2007; Hassan et al., 2001; Neely et
al., 2002) as well as RNA Polymerase II (Armstrong et al., 2002), gene
repressor proteins (Marenda et al., 2004; Sudarsanam et al., 2000),
and alternative splicing factors (Batsche et al., 2006; Tyagi et al.,
2009). While much work has focused on understanding howTable 3
lsd1 genetically interacts with mutations in PBAP but not BAP remodeling complexes.
Genotype # Wings % Ectopic Genetic interactiona
lsd1ΔN/+ 152 1 –
mor1/+ 152 5 Enhancement (+++)
mor1/lsd1ΔN 188 57
mor2/+ 267 0 No effect
mor2/lsd1ΔN 135 3
mor3/+ 319 52 Enhancement (+++)
mor3/lsd1ΔN 104 100
mor4/+ 106 0 No effect
mor4/lsd1ΔN 117 6
mor5/+ 130 34 Suppression
mor5/lsd1ΔN 192 11
mor6/+ 241 44 Enhancement (++)
mor6/lsd1ΔN 100 61
brm2/+ 134 3 Enhancement (+)
brm2/lsd1ΔN 170 14
snr1R3/+ 90 0 Enhancement (+)
snr1R3/lsd1ΔN 148 9
osa00090/+ 70 0 No effect
osa00090/lsd1ΔN 74 5
osa2/+ 84 0 No effect
osa2/lsd1ΔN 64 3
polybromoEY14080/+ 81 31 Enhancement (++)
polybromoEY14080/lsd1ΔN 127 50
polybromoEY14730/+ 28 50 Enhancement (++)
polybromoEY14730/lsd1ΔN 36 81
Bap180Δ86/+ 96 0 Enhancement (++)
Bap180Δ86/lsd1ΔN 101 18
Bap170Δ65/+ 114 2 Enhancement (++)
Bap170Δ65/lsd1ΔN 96 39
a Genetic enhancement or suppression was classiﬁed based on changes in either
expressivity (the degree of ectopic vein material present) or penetrance (changes in the
percentageofwingsdisplaying the ectopic veinphenotype).We scoredmildenhancement
(+) as an approximate 10–20% increase in penetrance, moderate enhancement (++) as
15–40% increase in penetrance, and strong enhancement (+++) as greater than 45%
enhancement.
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less is known about how remodeling complexes function in gene
repression. Therefore, we decided to focus on the group of histone
demethylase mutants that enhanced the snr1E1 wing phenotype. We
reasoned that since SNR1 can function to negatively regulate Brm
complex activities in intervein cells and prevent differentiation into
vein tissue (Marenda et al., 2004), mutations that enhanced the snr1E1
phenotype may function as corepressors and cooperate with SNR1 to
restrict speciﬁc target gene transcription.
Although the null mutant of lsd1 (lsd1ΔN) showed little genetic
interaction with snr1E1, we found that lsd1ΔN genetically interactedFig. 5. lsd1 genetically interacts with PBAP but not BAP complexes. (A) lsd1ΔN heterozygotes
(arrow). (C) lsd1ΔN shows no genetic interaction with snr1E1. snr1E1/lsd1ΔN transheterozygote
heterozygous for the brm2 null allele display normal wing patterning. (E) lsd1ΔN genetically
the PCV (arrow) [compare (D) and (E)]. (F) brm2 dominantly suppresses the snr1E1 ectopic v
ectopic vein material posterior to L5 (arrow). (H) Flies heterozygous for the point mutant al
and (I)]. lsd1ΔN/mor1 transheterozygotes have ectopic veinmaterial posterior to L5 and distal
the 5′UTR of the osa gene (osa00090/+) appear normal. (K) No genetic interaction observed
osa00090 transheterozygotes. (L) Flies heterozygous for the null allele Bap180Δ86 have norma
from Bap180Δ86/lsd1ΔN transheterozygotes have ectopic vein material distal to the PCV (arrow
(O) Bap170Δ65 genetically interacts with lsd1ΔN [compare (N) and (O)]. Wings from lsd1ΔN/with strong loss of function alleles ofmor and brm and snr1 (Table 3).
The lsd1ΔN mutation removes the presumptive lsd1 promoter and N-
terminal region, including the SWIRM domain (Di Stefano et al.,
2007). The wings of heterozygous lsd1ΔN/+ ﬂies appear normal
(Fig. 5A), and snr1E1/lsd1ΔN animals show no change in penetrance or
expressivity of the snr1E1 ectopic vein phenotype (Figs. 5B,C). The
wings of brm2 heterozygotes also appear normal (Fig. 5D), but doubly
heterozygous lsd1ΔN/brm2 wings display ectopic vein material distal
to the PCV (Fig. 5E). It was previously demonstrated that a
heterozygous brm2 mutation suppressed the ectopic vein phenotype
associatedwith heterozygous snr1E1 (Marenda et al., 2003). Therefore,have normal wings. (B) snr1E1/+ wings display ectopic vein material distal to the PCV
s have wings similar to snr1E1/+ animals (arrow) [compare (B) and (C)]. (D) Drosophila
interacts with brm2. lsd1ΔN/brm2 transheterozygotes have ectopic vein material distal to
ein phenotype [compare (B) and (F)]. (G) brm2, snr1E1/lsd1ΔN transheterozygotes show
lelemor1 display normal wings. (I) lsd1ΔN genetically interacts with mor1 [compare (H)
to the PCV (arrows). (J)Wings from heterozygous ﬂies carrying a P-element insertion in
between lsd1ΔN and osa00090 [compare (J) and (K)], as wings appear normal in lsd1ΔN/
l wings. (M) Bap180Δ86 genetically interacts with lsd1ΔN [compare (L) and (M)]. Wings
). (N) Flies heterozygous for the Bap170Δ65 null allele have wings that appear wild type.
Bap170Δ65 transheterozygotes have ectopic vein material distal to the PCV (arrow).
Fig. 6. LSD1 associates with the Brm complex in vivo. (A) LSD1 associates with the Brm
complex in vivo. Wild type embryo extracts (500 μg) were immunoprecipitated with
antibodies to SNR1. Proteins from whole extracts (E, 100 μg), supernatant (S), and
pellet (P) were fractionated by SDS-PAGE and transferred to a nitrocellulose
membrane. Western blots were probed with anti-LSD1 antibody. (B) LSD1 SWIRM
domain interacts with the Brm complex. GST-LSD1 fusions were generated that
contained either the SWIRM domain (LSD1-N) or the amine oxidase domain (LSD1-C)
and used for pull-down experiments. Similar amounts of immobilized GST fusions were
incubated with whole embryo extracts (500 μg) and interactions with the Brm complex
were assessed by immunoblot analyses using anti-SNR1 antibody. Extract lane
represents 100 μg of embryo lysate.
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animals would be suppressed by the additional heterozygous
mutation of snr1E1. Interestingly, the ectopic vein phenotype observed
in lsd1ΔN/brm2 wings was further enhanced by the snr1E1 allele (Figs.
5F,G; Table 2). The lsd1ΔN allele also demonstrated strong allele-
speciﬁc interaction with various mor mutants (Fig. 5, Table 3). For
example, the double heterozygous combination of lsd1ΔN withmor1, a
loss of function point mutation (Fig. 5H), leads to the appearance of
ectopic posterior crossveins by more than 50% (Fig. 5I). These data
suggest that some aspects of SNR1-dependent repression of Brm
functions in the wing intervein region depend on a fully functional
LSD1.
LSD1 associates with Brm complexes containing POLYBROMO/BAP180
and BAP170 (PBAP) but not OSA (BAP)
The SWI/SNF family of remodeling complexes can be divided into
two subclasses that have the same constellation of core subunits, with
differences in signature subunit composition (Mohrmann and
Verrijzer, 2005). In Drosophila, BAP complexes contain OSA as a
signature subunit while PBAP complexes contain POLYBROMO/
BAP180, BAP170 and SAYP but not OSA (Chalkley et al., 2008; Collins
and Treisman, 2000; Mohrmann et al., 2004; Moshkin et al., 2007).
Genetic studies have revealed pathway-speciﬁc regulation of target
genes by each of these Brm complex subclasses. Therefore, we tested if
lsd1ΔN displayed a preferential genetic interaction with mutations in
osa, polybromo (Bap180), or Bap170 (Carrera et al., 2008). We
observed no genetic interaction (Fig. 5K) between lsd1ΔN and a loss
of function osa mutant (osa00090) (Marenda et al., 2004; Treisman et
al., 1997; Vazquez et al., 1999) in the context of wing pattern
development. However, lsd1ΔN interacted strongly with null alleles
Bap180Δ86 and Bap170Δ65 (Figs. 5L–O, Table 3), suggesting that LSD1
corepressor functions may be targeted to PBAP-speciﬁc wing
development pathways.
LSD1 physically associates with the Brm complex
LSD1 is not a component of puriﬁed Brm complexes (Papoulas et
al., 1998); therefore, the observed genetic interactions may be either
direct or indirect. We addressed whether LSD1 could physically
associate with the Brm complex by using in vivo coimmunoprecipita-
tion and GST-pulldown assays. Drosophila embryo extracts were
immunoprecipitated with antibodies directed against the SNR1
subunit, as it is a stable core component of puriﬁed Brm complexes
(Papoulas et al., 1998; Zraly et al., 2004, 2003). LSD1 was found to
reside in the precipitated material (Fig. 6A), indicating that LSD1
could associate with the Brm complex in vivo. To help verify the
interaction we fused N- and C-terminal portions of Drosophila LSD1 to
GST and tested for Brm complex associations using an in vivo
pulldown assay (Fig. 6B) (Zraly et al., 2004). Wild type embryo
extracts were incubated with equivalent amounts of puriﬁed GST
alone, GST:LSD1-N (aa1–255) and GST:LSD1-C (aa258–876) fusions
immobilized on glutathione agarose. Complexes were tested for the
presence of SNR1 and only the GST:LSD1-N fusion containing the
SWIRM domain was found to interact. There was no detectable
interaction with the LSD1 amine oxidase domain that is essential for
the demethylase activity, suggesting that the LSD1 SWIRM domain is
sufﬁcient for interaction with the Brm complex in vivo.
LSD1 has an important role in wing development
LSD1 exhibits both genetic and protein interaction with compo-
nents of the Brm chromatin remodeling complex, suggesting that
LSD1 might have an important role in wing pattern formation in
cooperation with Brm functions. We previously found that the Brm
complex is widely expressed in wing tissues during the early pupalstage that corresponds to the developmental period when the cross
veins are forming (Marenda et al., 2004). Similarly, LSD1 is expressed
uniformly throughout the developing pupal wing, in both vein and
intervein cells (Figs. 7A,B) which is consistent with a broad role in
regulating the expression of genes required for proper wing vein
development.
In order to better understand the relationship between LSD1 and
the Brm complex, we employed a tissue-speciﬁc knockdown of lsd1 in
the developing wing using the GAL4-UAS system (Bernstein et al.,
2001). Short hairpin-RNAi (shRNAi) constructs, also known as
inverted repeats (IR), were expressed in a tissue speciﬁc manner to
deplete lsd1mRNA. Expression of an lsd1-IR using the GawB69B GAL4
imaginal disc driver led to ectopic veins anterior to the L2 longitudinal
vein and along the posterior crossvein (Fig. 7C), a phenotype similar
to the effects of losing Brm complex repressor functions. The
penetrance and expressivity of the knockdown phenotype was
greater in males as well as ﬂies reared at 29 °C, and enhanced by
the addition of a UAS-Dicer transgene that ampliﬁes the RNAi effect
(Bernstein et al., 2001; Dietzl et al., 2007).UAS-Dicer; lsd1-IR/GawB69B
males displayed the strongest phenotypes including crumpled,
broken and held-out wings (Fig. 7B and data not shown).
Wing veins develop as a consequence of speciﬁc signaling
pathways that are restricted to subsets of cells within the wing
primordium (Bier, 2000). The Brm complex contributes to the
development of the veins through activation functions in vein cells
and suppression of those pathways in the intervein cells (Marenda et
al., 2004). To help determine whether LSD1 cooperates with the Brm
complex in restricting vein development in a cell-speciﬁc manner, we
expressed the lsd1-IR in wing intervein cells through the use of a
blistered-GAL4 driver. Blistered (BS) is homologous to mammalian
serum response factor and the expression of BS is restricted to
intervein cells in the developing Drosophila wing (Johannes and
Preiss, 2002). We found that loss of lsd1 in intervein cells resulted in
ectopic vein formation including an ectopic anterior cross vein (ACV)
in a small percentage of animals (Fig. 7E). This data supports the view
that LSD1 functions to repress wing vein formation in intervein cells,
possibly by cooperating with the Brm complex to restrict vein-speciﬁc
gene transcription.
Fig. 7. LSD1 has an important role in wing development. (A and B) LSD1 is uniformly expressed in both vein and intervein cells in wild type OregonR Stage P7 (34–50 h APF) pupal
wings (Bainbridge and Bownes, 1981). (A) (−) antibody negative control. (B) Drosophila LSD1 antibody was used to detect expression in pupal wing cells. Insets in A and B show
magniﬁed views of the posterior cross vein region. (C–E) The GAL4-UAS systemwas utilized to express a short-hairpin RNAi (shRNAi) construct to knockdown lsd1 (lsd1-IR) in a cell
type or developmental time-speciﬁcmanner. The GawB69B driver leads to GAL4 expression in larval imaginal discs. The blistered driver (bs-GAL4) leads to GAL4 expression speciﬁc to
wing intervein cells during pupal development. All knockdown experiments were carried out at 29 °C. (C) Expression of lsd1-IR using the GAL4 driver GawB69B causes ectopic vein
development (arrows). (D) Overexpression of Dicer (UAS-Dicer) ampliﬁes the RNAi effects of the lsd1-IR. (E) Expression of lsd1-IR using bs-GAL4 in intervein cells leads to the
formation of an ectopic ACV in a small percentage of ﬂies (arrow).
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Although chromatin remodeling is an important component of
gene activation, its role in gene repression is not as well understood.
Our unbiased genetic screen using a weak dominant temperature
sensitive mutant allele of a key Brm complex regulatory subunit has
provided new insights into the involvement of chromatin remodeling
complexes in developmental tissue patterning. We found that
mutations in components of several signaling pathways, including
Notch, EGFR and DPP/TGFβ, genetically interacted in our assay. These
results, combined with candidate gene genetic analyses (this study
and Marenda et al., 2004), have conﬁrmed our previous hypotheses
that the Brm complex participates in both gene activation and gene
repression to help coordinate several key signaling pathways that lead
to proper animal patterning. Our results are largely concordant with
the results of previous limited screens that identiﬁed a set of dominant
modiﬁers of brmK804R mutant phenotypes (Armstrong et al., 2005;
Papoulas et al., 1998). Among 14 chromosomal deﬁciencies that
enhanced the brmK804R rough eye phenotype, we found that 6/14were
also dominant enhancers of the snr1E1wing phenotype and 3/14 were
suppressors (Tables S2, S3), suggesting that dominant modiﬁer
screens are effective tools for identifying unknown loci important for
Brm complex regulatory functions. Consistent with this view, the Brm
complex has been shown to interact the Notch ligand, Delta, in the
developing ﬂy eye (Armstrong et al., 2005). Our genetic modiﬁer
screen results presented here indicate that Notch signaling functions
may also be mediated through the Brm complex in the developing ﬂy
wing. Given the strong evolutionary conservation of these pathways,
we anticipate that the vertebrate SWI/SNF orthologs will play a
similarly important role in patterning the tissues of vertebrate animals.
What are the target genes regulated by the Brm complex in the
developing wing? We previously found that loss of snr1 functionresults in ectopic dpp and rhomboid expression in intervein cells
(Marenda et al., 2004). These data are consistent with the genetic
interactions shown in this report that were observed using mutants
affecting both the DPP and EGFR pathways. Our studies have
additionally provided an important insight into gene regulatory
factors beyond signaling pathways that contribute to transcription
repression in collaboration with chromatin remodeling complexes at
key points in the development and differentiation of tissues. In our
present analyses, we provide several lines of evidence suggesting that
the mechanism of Brm complex-mediated gene repression is not only
dependent upon a tight, physical and genetic relationship between
two core subunits, SNR1 and MOR, but also on histone lysine
demethylase enzymes.
MOR has an important role in regulating Brm complex stability and
facilitating SNR1 repressor functions
It has been reported that the full in vitro chromatin remodeling
activity of the mammalian BRM/BRG1 complex on reconstituted
nucleosomes can be accomplished with a subset of three or four core
components, including the SNF5 (SNR1), BAF155/BAF170 (MOR) and
BRM/BRG1 ATPase subunits that are highly conserved from yeast to
vertebrates (Phelan et al., 1999). Each of these subunits is required for
complex stability in vivo as RNAi depletion of the individual
components in cultured Drosophila cells leads to reduced stability of
the other subunits with corresponding changes in target gene
expression (this study and Moshkin et al., 2007; Zraly et al., 2006).
Loss of BRM function in vivo, using either a dominant negative ATPase
deﬁcient mutant (brmK804R) or an amorphic allele (brm2), can
suppress the snr1E1 wing phenotype (Marenda et al., 2004, 2003)
revealing an important role for SNR1 in restraining Brm complex
transcription activation functions. In contrast, mor mutants enhance
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and Kennison, 1997) and show allele-speciﬁc interaction with snr1E1,
suggesting an important functional relationship between the MOR,
BRM and SNR1 subunits. MOR likely serves as a scaffolding protein,
since physical associations were observed between SNR1-MOR and
MOR-BRM. Two independent domains of MOR, the SWIRM and SANT,
domains respectively, are critical for the binding interaction (Crosby
et al., 1999; Moshkin et al., 2007; Phelan et al., 1999). Therefore, the
contribution of SNR1 regulatory function on Brm complex chromatin
remodeling activities may depend on crosstalk through MOR since no
direct physical contacts between SNR1 and the BRM subunit have
been observed.
Histone demethylase enzymes function as coregulators of the Brm complex
An unbiased dominant modiﬁer genetic screen allowed us to
identify histone lysine demethylase enzymes as novel coregulators of
the Brm complex in controlling gene expression. Previous screens
looking for modiﬁers of a brm dominant negative allele (brmK804R) did
not uncover mutations in histone-modifying families, such as
acetyltransferases, deacetylases, and methyltransferases (Armstrong
et al., 2005). However, the wing patterning defect associated with
snr1E1 is highly sensitive, allowing us to observe subtle changes in
remodeling activities, and identify a family of epigenetic modiﬁers as
potential Brm regulators. We previously found that histone deacety-
lases (HDACs) were important corepressors that worked in direct
collaboration with the Brm complex (Marenda et al., 2004; Zraly et al.,
2004). In the present study, mutations in predicted demethylase
genes genetically interacted with snr1E1 and LSD1 was shown to
associate with the Brm complex in vivo, suggesting demethylases are
also potential cofactors. While a functional cooperation between
histone deacetylation and demethylation activities has been sug-
gested (Lan et al., 2008; Lee et al., 2006), our data implicates at least
three chromatin modifying activities—ATP-dependent chromatin
remodeling, histone deacetylation and demethylation—cooperating
to regulate tissue-speciﬁc gene repression through multiple bridging
interactions. In this scenario, the commitment of a gene promoter to
be repressed in a cell type-speciﬁc manner would depend on the
collateral inﬂuence of several chromatin modifying activities that
would serve to help establish a repressed transcriptional environ-
ment, refractory to the inﬂuence of signaling pathways operational in
adjacent cells.
There appears to be no correlation between the predicted
demethylase lysine substrate and enhancement/suppression of the
snr1E1 phenotype. This is not surprising, since a high degree of
functional redundancy exists amongst demethylase enzymes (Klose
and Zhang, 2007; Kouzarides, 2007; Shi and Whetstine, 2007). It is
likely that multiple demethylase enzymes cooperate to regulate a
variety of target genes. This is supported by experimental evidence
showing that knockdown experiments of individual demethylases, for
example lsd1, in cell culture often showed little or no change in global
methylation status, though signiﬁcant changes were observed on a
gene-speciﬁc level in vivo (Di Stefano et al., 2007; Rudolph et al.,
2007). Independent loss of function mutations in two JARID family
members, lid and Jarid2/CG3654, resulted in an opposite genetic
interaction with snr1E1. We observed that a loss of function mutation
in lid, (lid2) dominantly suppressed, whereas a loss of function
mutation in Jarid2 (CG3654EY02717) enhanced the ectopic vein
phenotype associated with snr1E1. LID is an H3K4me3/me2 speciﬁc
demethylase (Lee et al., 2007; Lloret-Llinares et al., 2008; Secombe et
al., 2007). JARID2 is predicted to have the same substrate speciﬁcity,
though overexpression analyses in cell culture experiments showed
no global increase in H3K4me3/2 (Lloret-Llinares et al., 2008). The
observed opposite genetic interaction with snr1E1 may reﬂect
differences in target gene regulation by LID and JARID2, either as a
consequence of different target genes controlled in the developingwing or through opposite mechanisms in controlling gene transcrip-
tion. Importantly, JARID2 homologs in Xenopus and mammalian
model systems physically associate with the Polycomb Repressor
Complex-2 (PRC2) and directly contribute to transcriptional repres-
sion by preventing the methylation of the histone lysine residues
correlated with transcriptional activation (Li et al., 2010; Pasini et al.,
2010; Peng et al., 2009; Shen et al., 2009) Therefore, mutation of
JARID2 (CG3654EY02717) may enhance the snr1E1 phenotype if the
normal role of CG3654 is to suppress transcription of a particular gene
involved in wing vein development.
The cell-fate decision to become vein or intervein is largely based
on cell-type speciﬁc expression of transcription factors (Blair, 2007;
de Celis, 2003). In vein cells, transcription factors with gene targets
that promote vein development are highly expressed, whereas those
with gene targets that block vein fate are repressed. In intervein cells,
the opposite is observed, with heightened expression intervein-
promoting factors and decreased expression of vein promoting
factors. The Brm complex has an important role in development of
both cell fates, serving a positive role to promote vein development in
vein cells, and repress vein development in intervein cells (Marenda
et al., 2004). The opposite genetic interaction phenotypes observed
with lid and Jarid2 could be partially explained if the Brm complex is
coordinating with the each speciﬁc demethylase to regulate different
target genes. We found that loss of function mutations in vein
promoting genes, such as Egfr, suppressed the snr1E1 phenotype
(Marenda et al., 2004). Our results suggest that LID and EGFR may
regulate the expression of similar target genes and indeed EGFR (as
well as other signaling pathways) may function in wing vein
development through LID. In this scenario, a loss of function mutation
in lid would result in a decrease in the expression of vein promoting
genes, thereby suppressing the snr1E1 ectopic vein phenotype.
Enhancement of the snr1E1 phenotype by Jarid2/CG3654EY02717 can
be explained if JARID2 promotes activation of genes required to block
vein differentiation, just as loss of function mutations in vein-
inhibiting factors, such as net, enhanced the snr1E1 phenotype
(Marenda et al., 2004).
LSD1 may be a cofactor speciﬁc to the PBAP family of Brm complexes
Our candidate genetic screen results suggest that histone lysine
demethylase enzymes are likely cofactors of Brm chromatin remodel-
ing activity. However, it is highly unlikely that stable physical
associations are made between the complex and all six demethylases.
We cannot eliminate the possibility that the Brm complex and
demethylase enzymes are independently regulating genes involved in
wing patterning or eliciting their functions on different targets at
different times during development to contribute to the ﬁnal read-out
of vein/intervein patterning in the adult wing. However, we did
observe a direct physical association between the Brm complex and
LSD1 in coimmunoprecipitation and GST-pulldown experiments,
implying that LSD1 is a potential cofactor of Brm complex remodeling
activities.
Our genetic epistasis experiments demonstrated an important in
vivo functional relationship between LSD1 and the core subunits of
the Brm complex, SNR1, MOR, and BRM. Brm complexes can be
subdivided into two groups: PBAP complexes contain BAP170,
POLYBROMO/BAP180, and SAYP, whereas BAP complexes contain
OSA (Chalkley et al., 2008; Collins et al., 1999; Kal et al., 2000;
Mohrmann et al., 2004; Papoulas et al., 1998). These complexes can
regulate target genes in a synergistic, antagonistic, or independent
manner (Mohrmann et al., 2004; Moshkin et al., 2007). BAP and PBAP
complexes likely have differential regulatory functions, since they
have distinct, but overlapping, localization patterns on larval salivary
gland polytene chromosomes (Mohrmann et al., 2004) and targeted
knockdown of OSA, POLYBROMO, or BAP180 using RNAi in cultured
Schneider cells, leads to differential expression proﬁles on whole
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SAYP likely have different roles in development, as mutation of each
leads to different abnormalities. For example, BAP180 is required for
proper egg shell development, whereas BAP170 is necessary to
stabilize BAP180, important for adult viability, and vein cell
differentiation (Carrera et al., 2008). OSA is necessary for photore-
ceptor development, normal embryonic segmentation, and wing
patterning (Treisman et al., 1997). BAP, but not PBAP complexes have
an important role in regulating cell cycle progression through mitosis
(Moshkin et al., 2007).
In mice, knockout of Baf180 causes misregulation of retinoic acid
receptor target genes and heart developmental defects, indicating
that PBAP complexes may have a role in nuclear receptor transcrip-
tional regulation (Wang et al., 2004). The LSD1 corepressor complex,
including the cofactor proteins, CoREST, and histone deacetylase,
HDAC1/2, have also been indicated in nuclear receptor transcriptional
regulation. LSD1 association in complexes containing the Estrogen
Receptor (ER) or Androgen Receptor (AR) leads to a switch in
methylated lysine speciﬁcity, and results in demethylation of mono-
and dimethylated H3K9 and gene activation (Garcia-Bassets et al.,
2007; Metzger et al., 2005).
It is not known how BAP vs. PBAP complexes are differentially
recruited to target genes. Recruitment of BAP complexes to speciﬁc
target genes may depend on the physical associations made by OSA
and sequence-speciﬁc transcription factors. For example, OSA is
required for expression of target genes associated with the transcrip-
tion factors Pannier and Apterous (Milan et al., 2004) and can
promote transcriptional repression of genes regulated by Wnt/
Wingless signaling (Collins et al., 1999; Collins and Treisman, 2000).
Our genetic epistasis experiments reveal that LSD1 cooperates with
PBAP, but not BAP containing complexes in the Drosophila wing,
suggesting that the physical association we observed between LSD1
and Brm complex may be limited to PBAP complexes and provide a
mechanism for selective target gene recruitment and regulation by
Brm remodeling complexes. Further analyses, such as GST-pulldown
and coimmunoprecipitation experiments using PBAP speciﬁc compo-
nents need to be performed to address this possibility.
LSD1 has cell type-speciﬁc role to repress vein cell differentiation
Ectopic vein development within intervein tissue can result from
two different possibilities: 1) the loss of a factor necessary to block
vein cell development, or 2) the gain of a factor that promotes vein cell
differentiation. Our knockdown experiments suggest LSD1/dCoREST
functions through the ﬁrst mechanism. Loss of LSD1/dCoREST
throughout the entire developing wing imaginal disc resulted in the
development of vein material in intervein tissue, but no changes in
vein morphology were observed. If LSD1/dCoREST normally func-
tioned to promote vein development, then loss throughout the entire
wing should have led to a loss of vein phenotype.
Several lines of evidence suggest that LSD1 may be capable of
regulating gene transcription in a cell-type or stage dependent
manner. The affect of homozygous loss of lsd1 on transcriptional
regulation of known target genes, including the Sodium Channel and
Nicotinic Acetylcholine Receptor-β is minimal in embryos and larvae,
but signiﬁcant in pupae (Di Stefano et al., 2007). This implies that
LSD1 has an important role in regulating gene transcription during
later developmental stages. Moreover, LSD1 negative regulation of the
homeobox genes, Ultrabithorax (Ubx) and abdominal-B (abd-B)
continues into adulthood, as lsd1 null animals display signiﬁcantly
increased expression of these genes as the animals continue to age (Di
Stefano et al., 2007). This stage-dependent requirement appears to be
conserved, as the conditional knock-out of LSD1 in the developing
mouse pituitary gland causes little or no morphological defects early
in pituitary development (E9–9.5), but signiﬁcantly alters cell-fate
determination choices during later stages (E17.5) (Wang et al., 2007).Furthermore, LSD1mediates both gene activation and gene repression
of different target genes by associating with several multisubunit
complexes (Lan et al., 2008; Wang et al., 2007).
Our knockdown and genetic epistasis experiments further support
the idea that LSD1 is important for regulating terminal differentiation,
since patterning phenotypes are similar to those observed with
defects in DPP and EGFR signaling, the pathways active during pupal
development, rather than observed with defects in HH signaling, an
early pathway component. Previous work has demonstrated an
important role in Brm complex involvement in EGFR, DPP, and
Delta/N signaling (Armstrong et al., 2005; Marenda et al., 2004). More
recently, it has been demonstrated that OSA, the deﬁning subunit of
the BAP complex, is required to activate EGFR targets in the
developing wing (Terriente-Félix and de Celis, 2009). In this regard,
the Brm complex may be cooperating with LSD1 to regulate several
conserved signaling pathways, but this cooperation may be tissue and
developmental time-point dependent.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2010.12.001.
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